Бесплатный автореферат и диссертация по биологии на тему

Исследование фактора некроза опухолей- α и дефензинов при инфаркте миокарда и некоторых инфекционных заболеваниях

ВАК РФ 03.00.04, Биохимия

Библиография Диссертация по биологии, кандидата биологических наук, Панютич, Елена Анатольевна, Минск

1. Войтенок Н.Н., Колесникова Т.е.» Мисуно Н.И. и др. Регуляция фактора некроза опухолей-® в моноцитах крови человека // Тез. докл. 1.I Всес. съезда гематологов и трансфузиологов, М., 1991, Т. 2, С. 359-360.

2. Маянский А.Н., Маянский Д.Н. Очерки о нейтрофиле и макрофаге Новосибирск: Наука» Сибирское отделение, 1983.-256 с.

3. Мисуно Н.И., Колесникова Т.О., Войтенок Н.Н. и др. Влияние дефензива ШР-1 на продукцию фактора некроза опухолей мономоноцитами человека in vitro. Тез. докл. III Всес. съезда гематологов и трансфузиологов, М., 1991 , Т. 2» С. 367.

4. Олд Л.Дж. Фактор некроза опухолей // В мире науки. 1988. --N.5. - С. 22-31.

5. Фрейдлин И.О. Система мононуклеарных фагоцитов. М.: Медицина, 1984. - 272 с.

6. Иммуноферментный анализ // Москва, "Мир" 1988. - 444 с.

7. Abe Y., Miyake М,, Sagawa Т. et al. Enzyme-linked immunosorbent assay (ELISA) for human tumor necrosis factor (h TNF) // Clinica Chemica Acta 1988 - Vol.176.-P.213-218.

8. Adolf G.R., Lamche H.R. Highly sensitive enzyme immunoassay for human lymphotoxin ( tumor necrosis factor ft) in serum // J. Immunol. Meth.- 1990.- Vol.130.- P.177-185.

9. Aggarwal B.6., Eessalu Т.Е., Hass P.E. Characterization of receptors for human tumour necrosis factor and their regulation by r-interferon // Nature.- 1985.- Vol.318. P. 665-667.

10. Akira S«, Hirano Т., Taga T. et al. Biology of multifunctional cytokines: lb 6 and related molecules ( IL 1 and ФМР ) // The PASEB J.- 1990.- Vol.4.- P. 2860-2867.

11. Andus T., Gelger T.,Hirano T. Action of recombinant human interleukin 6, interleukin 1ft and tumor necrosis faotor « on them RNA induction of aoute-phase proteins // Eur.J.Immunol. 1988. - Vol.18. - P.739-746.

12. Arakawa Т., Yphantis B.A. Molecular weight of recombinant human tumor necrosis factor-» // J. Biol. Chem.- 1987.- Vol.262,N.16.P.7484-7485.

13. Arditi M., Manoque K.R., Caplan M. Cerebrospinal fluid ca-chectin/tumor necrosis factor-» and platelet-activating factor concentrations and severity of bacterial meningitis in children // J. Infect .Bis. 1990. - Vol.162. - P. 139-147.

14. Arnaout M.A. Structure and function of the leukocyte adhesion molecules OB 11/СВЛ8 // Blood. 1990 - Vol.75, N.5. - P.1037--1050.

15. Arnold! J., Gerdes J., Plad H.B. Immunohistologio assessment of cytokine production of infiltrating cells in various forms of• 80 leprosy // Amer.J.Pathol. 1990 - Vol.137,N.4. - P.749-753.

16. Atkinson Т.Н., Murray A.W., Krilis S. Human tumour necrosis faotor -alpha (TNF-c* ) directly stimulates arachidonic acid release in human neutrophils // Immunol. 1990. - Vol.70 - P.82-87.

17. Banarjee R., Karpen S., Siekevitz M. Tumor necrosis factor-^» induces a KB sequence-specific DNA-blnding protein in human hepatoblastoma HepG2 cells // Hepatol. 1989. - Vol.10,N.6.P.1008-1013.

18. Barath P., Pishbein M.C., Cao J. et al. Detection and locali-localization of tumor necrosis faotor in human atheroma // Am. J. Cardiol. 1990 - Vol.65.- P. 297-302.

19. Baughman R.P., Strohofer S.A., Buchsbaum J. et al // Release of tumor necrosis factor by alveolar macrophages of patients with sarcoidosis.// J.Lab.Clin.Med. 1990. - Vol.115»N.1. - P.36-42.

20. Baumgarther H.R., Hosang M. Platelets,platelet-derived growth factor and arteriosclerosis // Experientia 1988 - V.44 - P.109--112.

21. Bendtzen K., Morling N., Pomsgaard A, et al. Association between HLA-DR2 and production of tumor necrosis factor a and inter-leukin 1 by mononuclear cells activated by lipopolysaccharideScand.J.Immunol. 1988 - Y.28 - P.599-606.

22. Berger M., Wetzler E.M., Wall is R.S. Tumor necrosis factor is the major monocyte product that increases complement receptor expression on mature human neutrophils // Blood.- 1988.- V. 71, N.1.- P.151-158.

23. Beutler B.D., Greenwald D., Hulmes J. et al. Identity of tumour necrosis factor and the macrophage-secre ted factor cachectin // Nature. 1985. - Vol.316. - P.552-554.

24. Beutler В., Cerami A. The biology of cachectin/TNF a primary mediator of the host response // Ann. Rev. Immunol. - 1989.-Vol.7. - P.625-655

25. Beutler B., Cerami A. Cachectin: more than a tumor necrosis factor // New Engl. J. Med. 1988.- Vol.316, N.7.- P.379-385.

26. Bevilacqua M.P. ,Gimbrone M.A. Inducible endothelial functions in inflammation and coagulation // Seminars in thrombosis and hemostasia.- 1987.- Vol.13, N.4.- P.425-433.

27. Bjerknes R., Vindenes H.,Laerum O.D. Altered neutrophilfunctions in patients with large burns // Blood Cells. 1990. -Vol.16 - P.127-143

28. Bonavida B. TNF: structure, mechanism of action, role in disease and therapy // DN & P. 1991.- Vol.4, N.2 - P.118-123.

29. Bonventre P.P., Thompson M.R., Adinolfi L.E. et al. Neutralization of toxic shock syndrome toxin-1 by monoclonal antibodies in vitro and in vivo // Infection and Immunity.- 1988.- Vol.56, N.1.- P.135-141.

30. Braquet P., Hosford D., Braquet M. et al. Role of cytokines and platelet-activating factor in microvascular immune injury // Int. Arch. Allergy Appl. Immunol. 1989. - Vol.88. - P. 88-100.

31. Brennan D.C., Yui M.A., Wuthrich R.P. et al. Tumor necrosis factor and IL-1 in New Zealand black/ white mice // J. Ironunol.1989. Vol.143, N.11P. 3470-3475.

32. Buck Oh., Digel W., Sohoniger W. et al. Tumor necrosis factor and hairy cell leukaemia // The Lancet.- 1988.- P. 402-403.

33. Calandra T., Baumgartner J.-D. ,Qrau G. Prognostic values of tumor necrosis faotor/cachectin, interleukin-1, interferon-r in the serum of patients with septic shook // J. Infect. Dis.1990. Vol.161. - P.982-987.

34. Cannon J.G., Van der Meer J.W.M., Kwiatkowski D. et al. Interleukin-1in human plasma: optimization of blood collection, plasma extraction, and radioiirraunoassay methods // Lymphokine Res. 1988. - Vol.7, N.4.- P. 457-467.

35. Cannon J.G., Tompkins R.G., Gelfand J.A. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever // J. Infect. Die. 1990. - Vol.161.P.79-84.

36. Carswell E.A., Old L.J., Kassel R.L. et al. An endotoxin-induced serum factor that causes necrosis of tumors // Proc. Natl. Acad. Sci. USA. 1975. - Vol.72, N.9. - P.3666-3670.

37. Carter A., Merchav S., Silvian-Draxler I. et al The role of interleukin-1 and tumour necrosis factor -alpha in human multiple myeloma // Br. J. Haemotol. 1990. - Vol.74, N.4. - P.424-431 .

38. Clark I.A., Chaudhri G. ,Cowden w.B. Roles of tumour necrosis faotor in the illness and pathology of malaria // Transaction of the Royal Society of Tropical Medicine and Hygiene. 1989. -Vol.83. ~ P.436-440.

39. Conkling P.R., Greenberg C.S., Weinberg J.B. Tumor necrosis factor induces tissue factor-like activity in human leukemia cell line U937 and peripheral blood monocytes // Blood. 1988.- 83Vol.72, N.1.- P. 128-133.

40. Caaja M.J., Flanders K.C., Bierapioa L. et al. Expression of tumor necrosis factor-alpha and transforming growth factor-beta 1 in acute liver injury // Growth Factors. 1988. - Vol.1, N.3. -P. 107-110.

41. Damas P., Reuter A., Gysen P. et al. Tumor necrosis factor and interleukin 1 serum levels during severe sepsis in humans // Critical Care Med. 1989. - Vol.17, N.10. - P. 975-978.

42. Dayer J.-M., Beutler В., Cerami A. Cachectin/ tumor necrosis factor stimulates oollagenase and prostaglandin Er> production by human synovial cells and dermal fibroblasts // J. Exp. Med.-1985.- Vol. 162.- P. 2163-2168.

43. Desoh Ch.E., Kovach N.L., Present W. et al. Production of human tumor necrosis factor from whole blood ex. vivo // Lymphokine Res. 1989. - V.8, N.2.- P. 141-146.

44. Dinarello C.A., Cannon J.D., Wolff S.M. et al. Tumour necrosis factor factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1 // J.Exp.Med. 1986. - Vol.163.-P. 1433-1450.

45. Djeu J.Y., Serbousek D., Blanchard D.K. Release of tumor necrosis factor by human polymorphonuclear leukocytes.// Blood. -1990. -Vol.76,N.7. P.1405-1409.

46. Duff G.W. Peptide regulatory factors in non-malignant disease // The Lancet. 1989. - P. 1432-1434.

47. Buncombe A.S., Heslop H.E., Turner M. et al. Tumor necrosis factor mediates autocrine growth inhibition in a chronic leukemia // J.Immunol.- 1989. Vol. 143 -P. 3828-3834.

48. Etaeis J.J., Kooistra T. Interleukin 1 and lipopolysacoharide induce an inhibitor of tissue-type plasminogen aotivator in vivo and in cultured endothelial cells // J. Exp. Med. 1986.Vol.163. P.1260-1266.

49. Engler R. Consequences of activation and adenosine-mediated inhibition of granulocytes during myocardial ischemia // Feder. Proc.- 1987. -Vol.46.- P.2407-2412.

50. Entman М.1., Youker K., Shappell S.B. Neutrophil adherence to isolated adult canine myocytes // J. Clin. Invest.- 1990.- Vol.85 P. 1497-1506.

51. Espevik I., Waage A., Faxvaag A. et al. Regulation of inter-leukin-2 and interleukin-6 production from T-cells: involvement of interleukin-1/? and transforming ^cowth factoiW? // Cell.Immunol. 1990. - Vol.126. - P.47-56.

52. Ivans R.D., Argiles J.M., Williamson D. Metabolic effects of tumour necrosis factor -a (oacheotin) and interleukin-1 // Clin. Sci. 1989. - Vol.77. - P.357-364.

53. Ivans D.A., Eng F.R.C.S. f Jacobs D.O. et al. The effects of tumor necrosis factor and their selective inhibition by ibupro-fen // Ann. Surg.- 1989. Vol.209.- P.312-321.

54. Feingold K.R., Soued M., Staprans I. et al. Effect of tumor necrosis factor (TKF) on lipid metabolism in the diabetic rat // J. Clin. Invest. 1989. - Vol.83 - P.1116-1121.

55. Fiohtner I., Lemm M., Becker M. et al. Determination of antineoplastic activity and toxicity of tumour necrosis factor (ШШ?) in animal experiments. Correlation to clinical findings.// Neo-plasma. 1990. - Vol.37, N.3. - P.301-315.

56. Pleischmann J., Selsted M.S., behrer R.I. Opsonic activityof MCP-1 and MCP-2, oationic peptides from rabbit alveolar macrophages // Diagnostic Microbia Infect Dis. 1985. - Vol.3 - P.233 -242.

57. Poa F.J.»Massaia M., Cardona S. et al. Production of tumor necrosis factor-alpha by chronic lymphocytic leukemia cells:a possible regulatory role of TNP in the progression of the disease // Blood. 1990. - Vol.76, N.2 - P. 393-400.

58. Folks M.T., Clouse K.A., Justement J. et al. Tumor necrosis factor a induces expression of human iramunodeficiency virus in a chronically infected T-cell clone // Proc. Natl. Acad. Soi. USA. -1989. Vol.86 - P. 2365-2368.

59. Pomsgaard A., Svenson M., Bendtyen K. Auto-antibodies to tumour necrosis faotor ® in healthy humans and patients with mmatory diseases and gram-negative bacterial infections // Scand. J. Immunol. 1989. - Vol.30. - P.219-223.

60. Pong Y., Lowry S.F. Tumor necrosis faotor in the pathophysiology of infection and sepsis // Clin. Immunol. Immunopath.- 1990.-Vol.55 P.157-170.

61. Purukawa S., Matsubara T.,Jujon K. et al. Peripheral blood monocyte /macrophages and serum tumor necrosis factor in Kawasaki disease //Clin. Immunol. Immunopathol.- 1988.- Vol.48.- P.247-251.

62. Gaillard R.C., Turnill D., Sappino P. et al. Tumor necrosis factor alpha inhibits the hormonal response of the pituitary gland to hypothalamic releasing factors // Endocrinol. ~ 1990.Vol.127, N.1. P.101-106.

63. Garuz T. Extracellular release of antimicrobial de fens ins by human polymorphonuclear leukocytes // Infect. Immunity.- 1987. -Vol.55. N. 3. P.568-571.

64. Ganz T., Selsted M.S., Lehrer R.I. Defensins // Eur. J. Hema-tol. 1990. - Vol.44. - P.1-8.

65. Gatanaga T., bentz R., Masunaka I. et al.// Identification of TNF/LT blockihg factor(s) in the serum and ultrafiltrates of human cancer patients // bymphokine Res. 1990 - Vol.9» N.2 -P.225-229.

66. Gifford G.E., Plick D.A. Tumor necrosis factor // Microbiolog.Sci. 1988 - Vol.5»N.4 - P.104-107.

67. Girardin E., Grau G.E., Bayer J.-M. et al. Tumor necrosis factor and interleukin -1 in the serum of children with severe infections purpura // New Engl. J. Med.- 1988 Vol.319» N.7 -P.397-400.

68. Gray P.W., Aggarwal B.B., Benton G.V. et al. Cloning and expression of DMA for human lymphotoxin, a limphokine with tumour necrosis activity // Nature. 1984. - Vol.312. - P.721-724.

69. Grau G.E.» Piguet P.-P.,Vassali P. Tumor necrosis factor and other cytokines in cerebral malaria: experimental and clinioal data // Immunol.Rev. 1989 - N.112 - P.59-66.

70. Greve J.W., Gouma D.J., Buurman W.A. Bile acids inhibit endotoxin- induced release of tumor necrosis factor by monocytes: an in vitro study // Hepatol. 1989. - Vol.10, N.4. - P. 454-458.

71. Groote M.A.» Martin M.A., Densen P. et al. Plasma tumor necrosis factor levels in patients with presumed sepsis // JAMA. -1989. Vol.262, N.2 - P.249-251.

72. Gulick T., Chung M.K., Pieper S.G. et al. Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte /^-adrenergic responsiveness // Proc. Natl. load. Sci. USA.- 1989. Vol.86. P. 6753-6757.

73. Hallahan D.E., Spriggs D.R., Beckett M.A. et al. Increased tumor necrosis factor a mRNA after cellular exposure to ionizing radiation // Pros. Natl. Acad. Sci. USA. 1989. - Vol.86P. 10104-10107.

74. Hasday J.D. ,Shan E.M., Lieberman A.P. Macrophage tumor necrosis factor-alpha release is induoed by oontaot with some tumors // J. Immunol. 1990. - Vol.172, N.1 - P.371-379.

75. Hata H., MatsuzakiH.,(Defeatsuki K. Autocrine growth by two cytokines , interleukin-6 and tumor necrosis faotor alpha, in the myeloma cell line EBM-1A // Acta. Hematol. 1990. - Vol.83.P. 133-136.

76. Hay H., Cohen J. Studies on the specificity of the L929 cell bioassay for the measurement of tumor necrosis factor // J. Clin. Lab. Immunol. 1989. - Vol.29. - P.151-155.

77. Henter J.-I., Soder 0., Andersson U. Identification of individual tumor necrosis factor/cachectin- producing cells after li~ lipopolysaocharide induction // Eur. J. Immunol. 1988. -Vol.18 - P. 983-988.

78. Higuchi M., Higashi N., Taki H. et al. Cytolytic mechanism of activated macrophages //J. Immunol.- 1990.- Vol.144.- P. 1425-1431.

79. Hinterberger W., Adolf G., Aichinger G et al. Purther evidence for lymphokine overproduction in severe aplastic anemia // Blood. 1988. - Vol.72, N.1 - P. 266-272.- 8:8 <*

80. Hirokawa M., Takatsu H., Niitsu H. et al. Serum tumor necrosis factor -a levels in allogeneic bone marrow transplant at recipients with acute leukemia // Tohoku J. Exp. Med. 1989. -Vol.159 - P. 237-244.

81. Hober D., Haque A., Wattre P. Production of tumour necrosis factor-alpha (THF-a) and interleukin -1 (IL-1) in patients with AIDS. Enhanced level of THF-a is related to a higher cytotoxic activity // Clin. Exp. Immunol. 1989. - Vol.78. - P.329-333.

82. Houde M., Arora D.J. Stimulation of tumor necrosis factor secretion by purified influenza virus neuraminidase // Cell. Immunol. 1990. - Vol.129, N.1. - P.104-111.

83. Jones l.Y., Stuart D.I., Walker N.P.C. Structure of tumour necrosis factor // Nature. 1989. - Vol.338, N.6212. - P.225-229.

84. Kashiwa I., Wright S.O., Bonavida B. Regulation of В cell maturation and differentiation // J. Immunol. 1987. - Vol.138. -P. 1383- 1390.

85. Kaufmaim S.H.E., Plesoh B.A. Cytokines in antibaoterial resistance: possible applications for immimomodulation // Lung. -1990. P. 1025- 1032.

86. Kawakami U., Cerami A. Studies of endotoxin-induoed decrease in lipoprotein lipase activity // J. Exp. Med. -1981.- Vol.154. -P. 631- 639.

87. Kindler V., Sappino A.P., Grau G.E. et al. The inducing role of tumor neorosis factor in the development of bactericidal granulomas during BCG infection // Cell. 1969. - Vol.56, N.5.P.731-740.

88. Kishimoto T. The biology of interleukin-6 // Blood. 1989. -Vol.74, N.1. - P. 1-10.

89. Kleinerman E.S., Knowles R.D., Bliok M.B. et al. Lithium chloride stimulates human monocytes to secrete tumor necrosis factor /caohectin // J. Leukoc. Biol. 1989. - Vol.46, N.5. -P. 484- 492.

90. Kramer S.M., Carver M.E. Serum-free in vitro bioassay for the detection of the tumor necrosis factor // J. Immunol. Meth. -1986. Vol.93 - P.201-206.

91. Kretschmer C., Jones D.B., Morrison K. et al. Tumor necrosis factor alpha and lymphotoxin production in Hodgkins disease // Amer. J. Pathol. 1990. - Vol.137, N.2 - P.341-351.

92. Kriegler M., Perez С., BePay K. A novel form of TNF /oacheo-tin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF // Cell. 1988. - Vol.53-P. 45- 53.

93. Kronke M., Hensel G., Schluter C. Tumor necrosis facnor and lymphotoxin gene expression in tumor oell lines // Cancer Res. -1988. Vol.48 - P. 5417- 5421.

94. Leeuwenberg J.F.M., Damme J. V., Meager T. et al. Effects of tumor necrosis factor on the interferon-r induoed major histocompatibility complex class II antigen expression by human endothelial cells // Eur. J. Immunol. - 1988. - Vol.18. - P.1469-1472.

95. Lehrer R.I., Ganz T. Antimicrobial polypeptides of human neutrophils // Blood. 1990. - Vol.76, N.11. - P. 2169- 2181.

96. Leszczynski D. Interleukin-1 alpha inhibits the effects of gamma-interferon and tumor necrosis factor alpha on the expression of the major histocompatibility antigens by the rat endothelium // Amer. J. Pathol. 1990. - Vol.136, N.1 - P.229-237.

97. Levine В., Kalman J., Mayer L. et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure // New Engl. J. Med. 1990. - Vol.323, N.4 - P. 236- 241.

98. Lichtenstein A.,Berenson J., Norman D. et al. Production of cytokines by bone marrow cells obtained from patients with multiple myeloma // Blood. 1989. - Vol.74, N.4 - P. 1266- 1273.

99. Lindemann A., Ludwig W.D., Oster W. et al. High-level secretion of tumor necrosis factor-alpha contributes to hematopoietic failure in hairy cell leukemia // Blood. 1989. - Vol.73., N.4. - P.880-884.

100. Lonnemann G., Van der Meer J.W.M., Gannon J.G. et al. Induction of tumor necrosis faotor during extracorporal blood purification // N. Engl. J. Med.- 1987.- Vol.317, N.15. ~ P.963.

101. Maisch B. Autoreactivity to the cardiac myocyte, connective tissue and the extracellular matrix in heart disease and post-cardiac injury // Springer Semin. Immunopathol. 1989. - Vol .11.-P. 369- 395.

102. Male D., Pryce G., Hughes 0. et al. Lymphocyte migration into brain modelled in vitro: control by lymphooyte activation, oytoki•m Q2 *nes, and antigen // Cell. Immunol. 1990. - Vol.127. - P. 1-11.

103. Manda T. ,Nishigaki P., Mori J. et al. Important role of serotonin in the antitumor effects of recombinant human tumor necrosis factor-» in mice // Cancer Res. 1988. - Vol.48 - P.4250-4255.

104. Mandrup-Poulsen Т., Bentdzen K., Dinarello Ch.A. et al. Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic /?-cell citotoxicity // J. Immunol. 1987. -Vol.139. - P. 4077-4082.

105. Matsushima K., Oppenheim J.J. Interleukin 8 and MCAF: novel inflammatory cytokines inducible by lb 1 and TNF // Cytokine.1989. Vol.1, N.1. - P. 2-13.

106. Marino M.W., Pfeffer L.M., Guidon P.T. et al. Tumor necrosis factor induces phosphorylation of 28-kDa mRHA cap-binding protein in human cervical carcinoma cells // Proc. Natl. Acad» Sci. USA. 1989. - Vol.86. - P. 8417- 8421.

107. Maury C.P.J., Teppo A.-M. Tumor necrosis factor in the serum of patients with systemic lupus erythematosus // Arthritis and Rheumatism. 1989. - Vol.32, N.2. - P. 146- 150.

108. Maury C.P.J., Teppo A.-M. Cachectin/tumor necrosis factor-a in the circulation of patients with rheumatic disease // Int. J. Tiss. Reac. 1989. - Vol.11, N.4. - P. 189- 193.

109. McCall J.L., Yun K., Funamoto S. et al. In vivo immunohisto-chemical identification of tumor necrosis factor/cachectin ni human lymphoid tissue // Amer. J. Path. 1989. - Vol.135, N.3. -P. 421- 425.

110. McLaughlin P.J., Ilwood N.J., Ramadl L.T. et al.// Improvement in sensitivity of enzyme-linked immunosorbent assay for tumor neorosis factor // Immunol. Cell. Biol. 1990. - Vol.68.• 55 *

111. Meager A., Leung H., Woolley J. Assays for tumour neorosisfactor and related cytokines // J. Immunol. Meth. 1989. - Vol. 116. - P.1-17.

112. Michie H.R., Manoque K.R., Spriggs D.R. et al. Detection of circulating tumor necrosis factor after endotoxin administration // New Ehgl. J. Med. 1988. - Vol.318, N.23 - P. 1481- 1486.

113. Moldawer L.L., Lowry S.P. Cachectin: its impact on metabolism and nutritional status // Ann.Rev. Nutr.- 1988.-Vol.8.- P.585-609.

114. Moldawer L.L., Marano M.A., Wei H. Cachectin/tumor neorosis factor alters red blood cell kinetics and induces anemia in vivo // FASEB J. 1989. - Vol.3. - P.1637-1643.

115. Molina J.-M., Scadden D.T., Byrn R. Production of tumor necrosis factor a and interleukin Л ft by monocytic cells infected with human immunodeficiency virus // J. Clin. Invest. 1989. -P.733-737.

116. Mooney D.P.,0reilly M., Gamelli R.L. Tumor necrosis factor and wound healing // Ann. Surg.- 1990.- Vol.211, N.2 P. 124-129.

117. Moore K.L., Esmon C.T., Esmon N.L. Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortio endothelial cells in culture // Blood. 1989. - Vol.73, N.1. - P. 159- 165.

118. Mori Н.» Teshlma М.К., Uesugi U. et al. Effect of immunostimu-lants and antitumor agents on tumor necrosis faotor (TNF) production // Int. J. Immunopharmao.- 1987.- Vol.9, N.8 P.881-892.

119. Myers A.K., RobeyJ.W., Price R.M. Relationship between tumo-tumour necrosis factor , eicosanoids and platelet-activating factor as mediators of endotoxin-induced shook in mice // Br. J. Pharmacol. 1990. - Vol.99. - P. 499- 502.

120. Nagai M., Saigusa Т., Shimanda Y. et al. Antibody to tumor necrosis factor (TNF) reduces endotoxin fever // Experientia. -1988. Vol.44. - P. 606-607.

121. Nawroth P.P., Bank I. ,Handley D. et al. Tumor necrosis faotor /cachectin interacts with endothelial cell receptors to induce release of interleukin 1 // J. Exp. Med. 1986. - Vol.163. No.6.~ P. 1363- 1375.

122. Nawroth P.P., Stem D.M. Endothelial cell procoagulant properties and the host response // Seminars in thrombosis and hemostasis. 1987. - Vol.13. N.4. - P.391-397.

123. Neilson I.R., Neilson K.A., Yunis E.J. et al. Failure of tumor necrosis faotor to produce hypotensive shook in the absenceof endotoxin // Surg. 1989. - Vol. 106, N.2 - P. 439- 443.

124. Nogate A.R.D., Yarbrough W.C. A comparison of the effects of intact and deaoylated 1 ipopolysacoharide on human polymorphonuclear leukocytes // J. Immunol* 1990. - Vol.144. - P.1404-1410.

125. Ohno I., Ohkawara Y., Yamauohi K. Production of tumor necrosis factor with IgE receptor triggering from sensitized lung tissue // Am. J. Respir. Cell. Mol. Biol. 1990. - Vol.3. N.4. - P. 285- 289.

126. Ohsawa T., Natori S. Expression of tumor necrosis factor ata specific developmental stage of mouse embryos // Develop. Biol.-1989. Vol.135, N.2. - P.459-461.

127. Old L.J. Tumor necrosis factor // Action, Role in Disease and Therapy. Basel, Karger. 1990. - P. 1- 30.

128. Opal S.M.,Cross A.S., Kelly N.M. Efficacy of a monoclonal antibody direoted against tumor necrosis factor in protecting neutropenic rats from lethal infection with pseudomonas aeruginosa // J. Infect. Die. 1990. - Vol.161. - P. 1148- 1152.

129. Osborn I»., Kunkel S., Nabel G.J. Tumor necrosis factor a and interleukin 1 stimulate the human imraunodeficieney virus enhancer by activation of the nuclear factor KB // Proc. Natl. Acad. Sci. USA. 1989. - Vol.86. - P. 2336- 2340.

130. Panyutioh A.V., Voitenok N.N., Lehrer B.I., Ganz T. Anenzyme immunoassay for human defensins // J. Immunol. Method. -1991. Vol.141, N.2.

131. Patek P.Q., Lin Y. Natural cytotoxic activity is not necessarily mediated by the release of tumour necrosis factor // Immunol. 1989. ~ Vol.67. - P. 509- 513.

132. Peri G., Chiaffarino P., Bernasconi S.et al. Cytotoxicity of activated monocytes on endothelial cells // J. Immunol. 1990.-Vol.144, N.4. P. 1444- 1448.

133. Picot S., Peyron P ., Vuillez J.-P. Tumor necrosis factor production by human macrophages stimulated in vitro by Plasmodium falciparum // Infection and Immunity. 1990. - Vol.58,N.1. P. 214- 216.

134. Pigatto P.D., Pigatto L.6., Bigardi A. et al. factors secreted by untreated psoriatic monocytes enhance neutrophil functions // J.Invest.Dermatol.- 1990. Vol.94,Н.Э. - P.372-376.

135. Piguet P.P., Grau G.E. Suboutaneous perfusion of tumor necrosis factor induces looal proliferation of fibroblasts, capillaries, and epidermal cells, or massive tissue necrosis // Amer. J. Pathol. 1990. - Vol.136, N.1 - P. 103- 110.

136. Piguet P.P., Collart M.A., Grau G.E. et al. Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis // Nature. 1990. - Vol.344. - P.245-247.

137. Pober J.C. TNP as an activator of vascular endothelium // Ann. Inst. Pas t ешУ Immunol. 1988. - Vol.139. - P.307-311.

138. Repo H., Jaattela M., Leirisalo-Repo U. et al. Production of tumour necrosis factor and interleukin 1 by monocytes of patients with previous Yersinia arthritis // Clin. Exp. Immunol.- 1988. -Vol.72. p.410-414.

139. Ricoiardi-Castagnoli P., Pirami L., Righi M. et al. Cellular sources and effects of tumor necrosis factor-alpha on pituitary cells and in the oentral nervous system // Ann. New York Acad. Sci 1990. - Vol.594. - P.156-168.

140. Riipi L., Carlson E. Tumor necrosis factor (TNP) is induced1. mice by Candida albicans: role of TNF in fibrinogen increase // Infection and Immunity. 1990. - P.2750-2754.

141. Ritchlin Ch.T., Winchester R.J. Potential mechanisms for coordinate gene activation in the rheumatoid synoviocyte: imlioa-tions and hypotheses // Springer. Semin. Immunopathol. 1989.- Yol.11. P.219-234.

142. Robbing D.S., Shirazi Y., Drysdale B.-E. et al. Production of cytotoxic faotor for oligodendrocytes by stimulated astrocytes // J. Immunol. 1987. - Vol.139, N.8. - P. 2593- 2597.

143. Robertson В., Dostal K., Daynes R.A. Neuropeptide regulation of inflammatory and immunologic responses // J. Immunol. 1988. -Vol.140. - P.4300-4307.

144. Roll J.T., Young K.M., Kurtz R.S. et al. Human rTNP a augments anti-bacterial resistance in mice: potentiation of its effects by recombinant human rIL-1« // Immunol.- 1990.- Vol.69.- P.316-322

145. Rood P.A., Lorence R.U., Kelley K.W. Serum protease inhibitor abrogation of newoastle disease virus enhancement of cytolysis by recombinant tumor necrosis faotor alpha and beta // J. National Cancer Inst. 1990. - Vol.82, N.3. - P. 213- 217.

146. Saarinen U.M., Koskelo E.-K., Teppo A.-M. et al.Tumor necrosis factor in ohildren with malignancies // Cancer Res. -1990. Vol.50. - P.592-595.

147. Sohall T.J., Lewis M., Koller K.J. et al. Molecular cloning and expression of a receptor for human tumor necrosis factor // Cell. 1990. - Vol.61, N.4. - P. 361- 370.

148. Sohlayer H.-J., Karck U., Ganter U. et al. Enhancement of neutrophil adherence to isolated rat liver sinusoidal endothelial cells by supernatanrs of lipopolysaocharide- activated monocytes // J.Hepatol. 1987. - Vol.5. - P.311-325.

149. Sohuger L., Varani J., Marks R.M. et al. Cytotoxicity of tumor necrosis factor-» for human umbilical vein endothelial cells // Lab. Invest. 1989. - Vol.61,N.1. - P.62-68.

150. Seckinger P.* Zhang J.H., Hauptmann B. et al. Characterization of tumor necrosis factor alpha (TNF-alpha) inhibitor: evidence of immunological oross-reao tivity with the tni receptor// Proc Natl. Acad. Sci. USA. 1990. - Vol.87, N.13. - P. 5188- 5192.

151. Seljelid R., Pigenohau У., Bogwald J. et al. Evidence that tumour neorosis induced by animated -3d polyglucose is mediated by a concerted action of local and systemic cytokines // Scand. J. Immunol. 1989. - Vol.30. - P. 687- 694.

152. SelmaJ K.W., Parooq M., Norton W.T. Proliferation of astrocytes in vitro in response to cytokines // J. Immunol. 1990. -Vol. 144. - P. 129- 135.

153. Semenzato G. Tumor neorosis factor: a cytokine with multiple biological activities // Br. J. Canoer. 1990. - Vol.61.P. 354- 361.

154. Shau H. Cytostatic and tumoricidal activities of tumor neorosis factor-treated neutrophils // Immunol. Lett. 1988.Vol. 17- P. 47- 51.

155. Sher Т., Rottem S., Gal lily R. Mycoplasma caprioolum membranes induce tumor neorosis factor a by a mechanism different from that of lipopolysaccharide // Cancer Immunol. Immunother. 1990. Vol.31- ~ P.86-92.

156. Shinmei M., Masuda K., Kikuohi T. et al. Interleukin 1» tumor neorosis factor, and interleukin 6 as mediators of cartilage destruction // Seminars in Arthritis and Rheumatism. 1989. -Vol.18, N.3. - P. 27- 32.

157. Shirai T., Yamaguchi H., Ito H. et al. Cloning and expression in Escherichia coli of the gene for human tumor necrosis factor // Nature. 1985. - Vol.313. - P.803-806.

158. Smith R.A., Baglioni C. The active form of tumor necrosis factor is a trimer // J. Biol. Chem. 1987. - Vol.262, No.15. -P. 6951- 6954.

159. Smith C.A., Davis Т., Anderson D. et al. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins // Science. 1990. - Vol.248. - P.1019-1023.

160. Steadman R., Petersen M.M., Williams D. et al. The selective augmentation by recombinant human tumor neorosis factor-alpha of neutrophil responses to pathogenic Esherichia ooli // Immunol. -1990. Vol.70. - P.133-135.

161. Stenbeck M.J., Roth J.A. Neutrophil activation by recombinant cytokines // Reviews of Infeotious diseases.- 1989.- Vol.11., N.4. P. 549- 568.

162. Stemme S., Pager G., Hans son G.K. MHO class II antigen expression in human vascular smooth muscle cells is induced by interferon-gamma and modulated by tumour necrosis factor by lymphotoxin // Immunol. 1990. - Vol.69. - P.243-249.

163. Territo M.C., Gana T., Selsted H.E., Lehrer R. Monocyte-ohe-motactic activity of defensins from human neutrophils // J. Clin. Invest. 1989. ~ Vol.84. - P.2017-2020.

164. Thornhill M.H., Kyan-Aung U., Lee Т.Н. et al. T cells and neutrophils exhibit differential adhesion to cytokine-stimulated endothelial cells // Immunol. 1990. - Vol.69. - P. 287- 292.

165. Tracey K.J., Pong U., Hesse D.G. et al. Anti-cachectin /TNF monoclonal antibodies prevent septic shock during lethal bacteremia // Nature. 1987. - Vol. 330. - P. 662- 664.

166. Tracey K.J., Cerami A. Cacheotin /tumor necrosis faotor and other cytokines in infectious disease // Current Opinion in Immunology, 1989. - Vol.1. - P. 454- 461.

167. Tracey K.J., Vlassara Н.» Cerami A. Cacheotin/tumor necrosis factor // Lancet. 1989. - P. 1122- 1125.

168. Vilcek J., Palombella V.J., Zhang U. et al. Mechanisms and significance of the mitogenio and antiviral actions of TNF // Ann. Inst. Pasteur/Immunol. 1988. - Vol.139. - P.307-311.

169. Vlassara Н. » Brownlee M., Manogue K.R. et al. Cachectin/TNP and IL-1 Induced by glucose-modified proteins: role in normaltissue remodeling // Soienoe. 1988. - Vol.240. - P. 122- 124.

170. Vlassara H., Moldawer L.» Chan B. Macrophage/monocyte receptor for nonenzymatioally glycosylated proteins is upregu-lated by caoheotin /tumor necrosis factor // J. Olin. Invest.1989. Vol.84. - P.1813-1820.

171. Voth R., Rossol S., Klein K. et al. Differential gene expression of IFU-c* and tumor necrosis factor-» in periferal blood mononuclear cells from patients with AIDS related complex and AIDS // J. Immunol. 1990. - Vol.144, N.3. - P. 970- 975.

172. Wallach D., Holtmann H. ,Aderka D. et al. Sensitizing effects and mechanisms of desensitization in regulation of the in vivo response to TUP // Ann. Inst. Pasteur/Immunol. 1988. -Vol.139. - P. 323- 327.

173. Wallis R.S., Amir-Tahmasseb M. ,Ellner J.J. Induction of interleukin 1 and tumor necrosis factor by mycobacterial proteins: the monocyte western blot // Proo. Natl. Acad. Sci. USA.1990. Vol.87. - P. 3348- 3352.

174. Warner S.J.C., Libby P. Human vascular smooth muscle cells // J. Immunol. 1989. - Vol.142, N.1. - P.100-109.

175. Warren J.B., Yabroff K.R., Remick D.G. et al. (Humor neorosis factor participates in the pathogenesis of acute immune complex alveolitis in the rat // J. Clin. Invest. 1989.- Vol.84. -P. 1873- 1882.

176. Weathers tone K.B., Rich E.A. Tumor necrosis f ac t or/cachec t in and interleukin-1 secretion by cord blood monocytes from premature and term neonates // Pediatrio Res. 1989. - Vol.25, N.4P. 342- 346.

177. Weetman A.P., Rees A.J. Synergistic effeots of recombinant tumour neorosis factor and interferon-gamma on rat thyroid oell growth and la antigen expression // Immunol. 1988. - Vol.63. ~P. 285- 289.

178. Weissman G. The role of neutrophils in vascular injury: a summary of signal transduction mechanisms in cell/cell interactions // Springer Semin. Immunopathol. 1989. - Tol.11.P. 235- 258.

179. Williams D.M., Magee D.M., Bonewald L.P. et al. A role in vivo for tumor necrosis factor alpha in host defense against Chlamidia trachomatis // Infection and Immunity. 1990. -Vol. 58, N.6. - P. 1572- 1576.

180. White D.J., Obers A. Tumour necrosis factor in organ transplantation // Ann. Acad. Med.- 1990. Vol.19,N.2. - P.142-146.

181. Wright S.D., Ramos R.A. , Hermanowski-Voea tka A. et al. Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: Dependence on lipopolysaccharide binding protein and CD14 // J. Exp. Med. 1991. - Vol.173. - P.1281- 1286.

182. Yokota S., Geppert T.D., Lipsky P.E. Enchancement of antigen-and mitogen- induced human T lymphocyte proliferation by tumor necrosis factor-a // J. Immunol. 1988. - Vol.140,N.2.P. 531- 536.

183. Yoshioka K,, Kakumu S„, Arao M. Immunohistochemical studies of intrahepatic tumor necrosis factor alpha in chronic liver disease // J. Clin. Pathol. 1990 - Vol.43, N.4. - P. 298- 302.

184. Yui S., Yamazaki M. Comparative studies on lipid and colony-stimulating factor-induced macrophage growth // J. Immunol.-1990. Vol.144, N.4. - P. 1461- 1465.

185. Yikejima Т., Okusawa J.W., Van der Meer, Dinarello C.A. Toxic shock syndrome is mediated by interleukin 1 and tumor necrosis factor // Rev. Infect. Disease. 1989. - Vol.11.P. 316- 317.